Cargill receives patent approval to improve its novel glucosamine production process
The United States Patent and Trademark office issued patent #8,034,925 to Cargill on Oct. 11, 2011. This patent, entitled “GLUCOSAMINE AND METHOD OF MAKING GLUCOSAMINE FROM MICROBIAL BIOMASS,” represents the latest improvements to Cargill’s unique non-shellfish glucosamine production processes.
The United States Patent and Trademark office issued patent #8,034,925 to Cargill on Oct. 11, 2011. This patent, entitled “GLUCOSAMINE AND METHOD OF MAKING GLUCOSAMINE FROM MICROBIAL BIOMASS,” represents the latest improvements to Cargill’s unique non-shellfish glucosamine production processes.
“Cargill continues to pursue innovations for its glucosamine products and processes,” said Mark Christiansen, acidulants product line manager, Cargill Corn Milling North America. “We are committed to producing safe, quality-consistent Regenasure® glucosamine at our state-of-the-art facility in Eddyville, Iowa.”
This patent describes a unique glucosamine composition formed from a vegetarian-based material, as well as a kosher fungal biomass-derived glucosamine suitable for human consumption.
Cargill’s Regenasure® glucosamine is the only U.S. produced, Generally Recognized As Safe (GRAS) glucosamine commercially available which is also suitable for vegetarians and those with shellfish allergies.
Cargill recognizes and respects the intellectual property of others and is committed to protecting and enforcing its own intellectual property rights. Cargill has neither licensed nor authorized any other parties to produce glucosamine utilizing the technology covered under patent #8,034,925.
The United States Patent and Trademark office also issued patent #7,816,514 to Cargill on September 2, 2010 for additional features of its glucosamine technology.
Source: Cargill
All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
